Zhaoyuan Pharma (06127) Projects H1 Net Profit Up 885%-1377%, CXO Sector Backed by Drug Export Surge
Zhaoyuan Pharma (06127) expects first-half 2026 net profit attributable to shareholders to increase 884.9% to 1,377.4% year-over-year, according to the company's earnings guidance. The growth is supported by a record-high scale of domestic innovative drug business development exports this year,
JOINN-2.55%
GateNews·07-14 23:21
